CVR number 36502746
Industry 87.9090 Other residential care activities

MANDECENTRET BOTILBUD ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.2% 0.8% 1.0% 0.6% 0.7%  
Credit score (0-100)  44 93 87 96 93  
Credit rating  BBB AA A AA AA  
Credit limit (mDKK)  0.0 1.7 1.2 1.4 2.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  28 37 42 51 63  
Gross profit  17.0 23.0 27.5 29.9 39.3  
EBITDA  0.1 3.3 4.0 2.2 5.8  
EBIT  0.1 3.2 3.8 1.1 3.9  
Pre-tax profit (PTP)  0.0 3.1 3.6 1.0 3.9  
Net earnings  0.0 3.1 3.6 1.0 3.9  
Pre-tax profit without non-rec. items  0.0 3.1 3.6 1.0 3.9  
 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  0.0 0.6 2.9 7.9 7.5  
Shareholders equity total  5.1 8.2 8.7 6.2 10.1  
Interest-bearing liabilities  1.5 1.6 0.1 5.0 4.4  
Balance sheet total (assets)  9.2 14.5 14.4 17.7 19.7  
Net Debt  -4.7 -8.0 -6.0 1.5 -0.6  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  28 37 42 51 63  
Net sales growth  31.1% 31.3% 13.4% 22.4% 23.1%  
Gross profit  17.0 23.0 27.5 29.9 39.3  
Gross profit growth  19.0% 35.1% 19.5% 8.7% 31.4%  
Employees  31 36 45 54 60  
Employee growth %  29.2% 16.1% 25.0% 20.0% 11.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9 15 14 18 20  
Balance sheet change%  1.0% 59.0% -1.2% 23.0% 11.7%  
Added value  0.1 3.3 4.0 1.3 5.8  
Added value %  0.3% 8.9% 9.5% 2.5% 9.2%  
Investments  0 1 2 4 -2  
Net sales trend  3.0 4.0 5.0 5.0 5.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.3% 8.9% 9.5% 4.3% 9.2%  
EBIT %  0.3% 8.7% 9.1% 2.2% 6.2%  
EBIT to gross profit (%)  0.5% 13.9% 13.7% 3.7% 9.8%  
Net Earnings %  0.0% 8.4% 8.6% 1.9% 6.2%  
Profit before depreciation and extraordinary items %  0.0% 8.7% 9.1% 4.0% 9.2%  
Pre tax profit less extraordinaries %  0.0% 8.4% 8.7% 1.9% 6.2%  
ROA %  1.0% 27.0% 26.1% 7.0% 20.7%  
ROI %  1.2% 37.8% 40.6% 11.2% 30.3%  
ROE %  0.0% 46.6% 42.6% 13.3% 47.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  55.9% 56.5% 60.6% 35.1% 51.1%  
Relative indebtedness %  14.4% 17.2% 13.5% 22.5% 15.4%  
Relative net indebtedness %  -7.6% -8.8% -1.1% 15.6% 7.4%  
Net int. bear. debt to EBITDA, %  -5,307.7% -243.3% -152.4% 67.7% -10.9%  
Gearing %  29.9% 19.4% 0.7% 80.0% 43.3%  
Net interest  0 0 0 0 0  
Financing costs %  4.9% 5.9% 19.2% 5.5% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.6 2.2 2.0 0.9 1.3  
Current Ratio  2.6 2.2 2.0 0.9 1.3  
Cash and cash equivalent  6.2 9.6 6.1 3.5 5.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  38.5 42.9 46.7 43.2 39.6  
Trade creditors turnover (days)  6.8 6.4 12.3 9.7 13.4  
Current assets / Net sales %  32.6% 37.8% 27.4% 19.1% 19.5%  
Net working capital  5.6 7.6 5.8 -1.7 2.6  
Net working capital %  19.9% 20.6% 13.9% -3.4% 4.1%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  1 1 1 1 1  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0